Literature DB >> 6317238

Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.

H N Willcox, J Newsom-Davis, L R Calder.   

Abstract

We have previously reported that cell suspensions prepared by mechanical dispersion of thymic tissue from myasthenia gravis (MG) patients spontaneously synthesise anti-acetyl-choline receptor autoantibodies (anti-AChR) in culture in many cases. We now find a 2-200-fold greater anti-AChR production if the cell suspensions are prepared with the proteolytic enzymes collagenase and dispase (THYC + D). This difference has been seen in seven of the first 10 cases tested. Using these enzymes, we now also find comparable anti-AChR synthesis by MG lymph node cells, confirming the presumed extra-thymic production of much of this autoantibody. The increased anti-AChR synthesis by THYC + D is not simply a mitogenic effect of the enzymes, but apparently depends on several distinct factors: (1) plasma cells are often isolated much more efficiently--particularly by dispase--than by mechanical dispersion of these tissues (or of 'normal' tonsil), and the same may also be true of specific B cells. (2) The greatly increased numbers of fibroblasts, macrophages and other adherent cell types exert 'feeder' effects which enhance anti-AChR and total IgG production non-specifically. (3) Specific antigen presenting cells (APC) may also be recovered more efficiently and selectively stimulate anti-AChR production by B memory cells. These results imply that APC, plasma cells, and perhaps also B memory cells are recovered from germinal centres much more efficiently by enzymic than by conventional dispersion, a conclusion that may be relevant to workers studying antibody forming and memory B cells in other systems or species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317238      PMCID: PMC1535867     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Interactions of cooling rate and protective additive on the survival of washed human erythrocytes frozen to -196 degrees C.

Authors:  G J Morris; J Farrant
Journal:  Cryobiology       Date:  1972-06       Impact factor: 2.487

2.  Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation.

Authors:  H Okudaira; K Ishizaka
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

3.  Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies.

Authors:  N Tidman; G Janossy; M Bodger; S Granger; P C Kung; G Goldstein
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

4.  Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology.

Authors:  G K Scadding; A Vincent; J Newsom-Davis; K Henry
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

Review 5.  The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory.

Authors:  G G Klaus; J H Humphrey; A Kunkl; D W Dongworth
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 6.  The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells.

Authors:  J G Tew; R P Phipps; T E Mandel
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 7.  Induction, maintenance and regulation of antibody responses due to persistent antigen and accessory cells.

Authors:  A B Stavitsky
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 8.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

9.  The value of thymectomy in myasthenia gravis: a computer-assisted matched study.

Authors:  J M Buckingham; F M Howard; P E Bernatz; W S Payne; E G Harrison; P C O'Brien; L H Weiland
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

10.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

View more
  19 in total

1.  Traffic of peripheral B and T lymphocytes to hyperplastic, preneoplastic thymuses of AKR mice.

Authors:  S A Michie; R V Rouse
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  The thymus in seronegative myasthenia gravis patients.

Authors:  N Willcox; M Schluep; M A Ritter; J Newsom-Davis
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

Review 3.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.

Authors:  T Kirchner; S Tzartos; F Hoppe; B Schalke; H Wekerle; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands.

Authors:  S M McLachlan; C A Pegg; M C Atherton; S L Middleton; A Dickinson; F Clark; S J Proctor; G Proud; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

6.  Microenvironments in the normal thymus and the thymus in myasthenia gravis.

Authors:  M Bofill; G Janossy; N Willcox; M Chilosi; L K Trejdosiewicz; J Newsom-Davis
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

Review 7.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

8.  Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.

Authors:  H N Willcox; J Newsom-Davis; L R Calder
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Cellular aspects of myasthenia gravis.

Authors:  S Berrih-Aknin; S Cohen-Kaminsky; D Neumann; D Safar; B Eymard; C Gaud; P Levasseur; S Fuchs; J F Bach
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

10.  Greatly improved recovery of in vitro B-memory cell function after enzymic dispersion of immunized mouse spleens.

Authors:  A N Brown; H N Willcox
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.